Greg Dokshin, PhD
Senior Manager, Gene Editing Research, Vertex Pharmaceuticals
Former RTI Lab: Postdoctoral Fellow, Mello Lab
Training Period: 2015 - 2018
Prior Academic Degree Institution: MIT
Awards: American Cancer Society Postdoctoral Fellow
I lead a team dedicated to tailoring CRISPR-based gene editing systems to specific therapeutic strategies for rare diseases using a diverse set of genetic and protein engineering tools.